Holen Sie sich die Stockscreener-App
1.06
4.50%
-0.05
Schlusskurs vom Vortag:
$1.11
Offen:
$1.05
24-Stunden-Volumen:
16,608
Relative Volume:
0.45
Marktkapitalisierung:
$12.27M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.00
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-5.44%
1M Leistung:
-4.50%
6M Leistung:
+13.98%
1J Leistung:
-43.77%
1-Tages-Spanne:
$1.05
$1.105
1-Wochen-Bereich:
$1.05
$1.14
52-Wochen-Spanne:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.06 | 12.85M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
152.88 | 69.31B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.16 | 47.34B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.76 | 43.88B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.75 | 21.08B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
404.81 | 13.78B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
How to build a custom watchlist for TherapeuticsMD Inc.2025 Historical Comparison & Real-Time Stock Movement Alerts - Newser
Chart based exit strategy for TherapeuticsMD Inc.Trade Risk Assessment & Community Verified Trade Signals - Newser
TherapeuticsMD Inc. stock trend outlook and recovery pathMarket Activity Recap & Verified Entry Point Signals - Newser
Historical volatility pattern of TherapeuticsMD Inc. visualizedQuarterly Earnings Report & Real-Time Volume Trigger Notifications - Newser
Advanced analytics toolkit walkthrough for TherapeuticsMD Inc.Market Risk Summary & Daily Chart Pattern Signals - Newser
Will TherapeuticsMD Inc. stock recover after recent dropCEO Change & Weekly Watchlist for Hot Stocks - Newser
Identifying reversal signals in TherapeuticsMD Inc.CEO Change & Weekly Return Optimization Alerts - Newser
Will TherapeuticsMD Inc. outperform the marketBull Run & Verified Trade Idea Suggestions - Newser
Should value investors consider TherapeuticsMD Inc.2025 Risk Factors & Fast Gain Swing Alerts - خودرو بانک
How to escape a deep drawdown in TherapeuticsMD Inc.2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Visual analytics tools that track TherapeuticsMD Inc. performanceJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Risk vs reward if holding onto TherapeuticsMD Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What technical models suggest about TherapeuticsMD Inc.’s comebackJuly 2025 Reactions & Safe Capital Growth Tips - Newser
Does TherapeuticsMD Inc. stock benefit from AI growthQuarterly Earnings Report & Free Community Consensus Stock Picks - خودرو بانک
Is TherapeuticsMD Inc. a candidate for recovery playJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
How to use Fibonacci retracement on TherapeuticsMD Inc.July 2025 Action & Precise Swing Trade Entry Alerts - Newser
Should you wait for a breakout in TherapeuticsMD Inc.July 2025 Technicals & Expert Curated Trade Setup Alerts - Newser
Nasdaq Moves: Does TherapeuticsMD Inc. stock benefit from AI growthMarket Activity Summary & Low Drawdown Investment Strategies - خودرو بانک
Screener Results Flag TherapeuticsMD Inc. as Oversold getLinesFromResByArray error: size == 0 - thegnnews.com
Is TherapeuticsMD Inc. part of any major indexEarnings Growth Summary & Technical Buy Zone Confirmation - خودرو بانک
What recovery options are there for TherapeuticsMD Inc.July 2025 Selloffs & Technical Entry and Exit Alerts - Newser
TherapeuticsMD Inc. stock volume spike explainedTrade Exit Report & Low Drawdown Trading Strategies - Newser
Long term hold vs stop loss in TherapeuticsMD Inc.2025 Volatility Report & AI Powered Market Trend Analysis - Newser
When is the best time to exit TherapeuticsMD Inc.July 2025 Movers & Weekly High Return Opportunities - Newser
TherapeuticsMD Inc. stock trend forecastTrend Reversal & Reliable Trade Execution Plans - Newser
How to track smart money flows in TherapeuticsMD Inc.2025 Market Overview & Long-Term Growth Stock Strategies - Newser
Is TherapeuticsMD Inc. stock ready for a breakoutMarket Volume Report & Low Drawdown Momentum Trade Ideas - Newser
Quantitative breakdown of TherapeuticsMD Inc. recent move2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - Newser
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Therapeuticsmd Inc-Aktie (TXMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
1.48%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):